NASDAQ·US·Biotechnology
REGNREGN
0คะแนน
สรุป
ปานกลาง
ความมั่นใจ 89%
$686.36—
Today's session
Upside?
+26.0%
FV $864.59
P/E (TTM)?
16.5
Earnings yield
FCF yield?
4.5%
Mcap $71.96B
ถือ
Fundamental buy·Technical neutral
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Strongly positive
5 · 1 · 1
Strengths
- High return on invested capital16%
- Low ROE volatility — durable franchise2.2 pp
- Net cash on the balance sheet-1.3×
- Modestly undervalued vs. consensus FV26%
- Analyst consensus heavily Buy-skewed
Risks
- Inconsistent profitability4/10
Watchlist
- Gross margins under pressure
$686.36+21.3%
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
4 of 5 models · trimmed-mean consensus
Consensus FV
$864.59
Upside
+26.0%
Now $686.36
Our FV$864.59
Price$686.36
$312.36$1,504.45
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Market cap
$71.96B
P/E (TTM)?
16.5
FCF yield?
4.5%
Dividend
—
52w range
$481.15 – $811.29
Score confidence
89%
Data completeness
Last updated 4/30/2026, 5:21:55 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer